Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Glyn Edwards MBE

Glyn Edwards MBE

individual
Ecosystem influencer

About

Glyn Edwards MBE is a UK biotechnology executive and board director best known for serving as CEO of Summit Therapeutics from April 2012, where he led the company through its NASDAQ listing and focused it on infectious and rare disease programs. Earlier, he was interim CEO of the BioIndustry Association and CEO of Antisoma plc, and he previously held business-development leadership at Therapeutic Antibodies Ltd. More recently, he has held board roles at OrthoSon and MitoRx Therapeutics.

Areas of interest

biotechrare diseaseinfectious diseaseoncologymedtechdegenerative diseasemitochondrial therapeutics